MHRA approves licence 8th August 2018

MHRA approves licence 8th August 2018

Biotherapy Services Limited


MHRA approves licence MIA/(IMP) for the point-of-care manufacture of RAPIDTM Biodynamic Haematogel treatment.


Biotherapy Services Ltd. announces the granting of the MIA/(IMP) and “Specials” licences for our proprietary RAPIDTM Biodynamic Haematogel wound care treatment for complex and chronic wounds, was issued on 8thAugust 2018


For further information, please contact:

Biotherapy Services Ltd

Janet Hadfield, Chief Executive Officer ++44 (0) 207 788 7828